|Day Low/High||92.11 / 95.87|
|52 Wk Low/High||66.93 / 101.73|
After starting with a sharp selloff on the latest trade tensions with China, U.S. stocks bounced back to end mostly higher Thursday.
The Nasdaq was the lone major U.S. index to close trading in the green Wednesday.
U.S. stock futures are mixed amid reports of an escalation of trade tensions between the U.S. and China; Apple posts stronger-than-expected quarterly profit; analysts are non-committal on Tesla.
Here's what you need to know now for Wednesday, July 18.
Companies didn't hesitate to pull the trigger on some big deals in the quarter.
On the heels of the landmark antitrust decision, Bain's Kara Murphy expects to see more healthcare transactions.
The ruling has a positive read-across for Cigna's pending acquisition of Express Scripts and CVS' deal for Aetna, according to Leerink's Ana Gupte.
Tesla CEO Elon Musk is a making a big gamble by cutting loose 9% of the company's workforce. Here's one hot trade off the AT&T/Time Warner deal decision.
The AT&T-Time Warner deal decision is bullish for one healthcare company in particular. Why can't private equity spend its money? And is Tesla making a wrong move?
The health and human services secretary calls for getting rid of rebates between pharmacy benefit managers and drug companies, but senators had plenty of other issues with the Trump administration's blueprint to lower drug prices.
Donald Trump's meeting with Kim Jong Un was upbeat, but the market has yawned. Bankers are on pins and needles ahead of a judge's decision Tuesday on AT&T's bid for Time Warner. Meanwhile, are investors truly bullish on the market?
Here's what you need to know now for Monday, June 11.
Cigna CEO David Cordani is game on in trying to shape the future of healthcare. He talks with TheStreet on where he thinks things are headed.
President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.
President Trump and HHS Secretary Alan Azer rolled out a plan to lower out of pocket costs for consumers when it comes to drug prices. Now comes the hard part.
It has been yet another long week on Wall Street. On Friday, investors are greeted with a mild Nvidia earnings related selloff. Be on the lookout for valuation-based tech stock downgrades in the week ahead.
Since taking office, President Trump has talked big on reining in drug prices, but the administration's lack of action leaves most expecting a May 11 speech that tastes like a nothing burger.
Walmart has elected to follow the Centers for Disease Control and Prevention guidelines for first time opioid patients, limiting prescriptions to no longer than a seven day supply.
It was Warren Buffett weekend as the famed investor held court with Berkshire Hathaway investors. Here are several observations for investors.
Consistency in discipline will make the difference.
Cigna CEO David Cordani isn't ready to declare the future of healthcare will mean people go to retail stores to get all problems addressed.
Apple's earnings after the closing bell on Tuesday could set the tone for a meandering stock market. If the tech giant doesn't deliver in a big way, notably with its cash allocation plans, the broader market could easily tank.
Cigna CEO David Cordani talks to TheStreet on the progress of getting company's big deal for Express Scripts passed by regulators.
Cigna CEO David Cordani discusses the progress on closing the company's big deal for PBM Express Scripts.
Doubleline's Gundlach Launches Facebook Short Campaign, Greenlight's Einhorn believes Assured Guarantee has massive losses "baked in" while Bill Ackman Protégé Scott Ferguson eyes a break up of Britain's WhitBread plc.
The company's underwriting margins and traditional health insurance business are key areas to watch, according to BMO Capital Markets' Matthew Borsch.
Paying for healthcare costs could be among your biggest concerns after retiring. Here's how the possible tie-in might change the way you access care.
A study of analyst recommendations at the major brokerages shows that Express Scripts Holding Co is the #85 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.